Products and Investments

Products, customers and applications

Indications and sectors



Example products



Protecting crops from harmful fungal diseases; improving plant health

AgCelence® (umbrella brand), boscalid, dimethomorph, F 500®, Initium®, metiram, metrafenone, Xemium®



Reducing competition from weeds for water and nutrients

Basta®, Clearfield®, dimethenamid-P, Engenia®, Finale®, imazamox, Kixor®, Liberty®, pendimethalin, topramezone



Combating insect pests in agriculture and beyond, such as in the fields of public health, professional pest control and landscape maintenance

Alpha-cypermethrin, chlorfenapyr, fipronil, Inscalis®, Interceptor®, Nealta®, teflubenzuron, Termidor®

Functional Crop Care


Products for plant health and increased yield potential that go beyond traditional crop protection, such as biological crop protection, seed treatments, polymers and colorants

COPeO®, Flo Rite®, ILeVO®, Integral®, Limus®, Nodulator® PRO, PONCHO®, Serifel®, Systiva®, Vault® HP, Velondis®, Vizura®, VOTiVO®

Seeds & Traits


Seeds and traits for key field crops such as canola (oilseed rape), cotton, soybean and wheat, as well as vegetable seeds

Credenz®, FiberMax®, InVigor®, LibertyLink®, Nunhems®, Stoneville®


Capital expenditures (capex) amounted to €157 million in 2018. Major projects included the startup of new production capacities for our fungicide Revysol® in Hannibal, Missouri, and our insecticide Inscalis® in Elbeuf, France, as well as modernization measures at plants in North America and Europe. A state-of-the-art global breeding station for the vegetable seeds business was opened at the Nunhem site in the Netherlands. We also invested in plant infrastructure in North America and research and development in Limburgerhof, Germany. To meet the continuing high demand for our innovative solutions in the future, we will invest around €1,270 million in developing and expanding our infrastructure and in our production and formulation capacities for active ingredients between 2019 and 2023. This increase in investment is driven by the expansion of production capacities for the planned market launches of a large number of products from our crop protection pipeline, as well as for the acquired businesses.